Drug Information

Drug General Information
Drug ID
D0A8QA
Former ID
DNC014352
Drug Name
2-Chloro-5-(2-methylquinolin-7-yl)nicotinonitrile
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530843]
Formula
C16H10ClN3
Canonical SMILES
CC1=NC2=C(C=C1)C=CC(=C2)C3=CN=C(C(=C3)C#N)Cl
InChI
1S/C16H10ClN3/c1-10-2-3-11-4-5-12(7-15(11)20-10)14-6-13(8-18)16(17)19-9-14/h2-7,9H,1H3
InChIKey
FCXAJLFDBPZDJD-UHFFFAOYSA-N
PubChem Compound ID
46888088
Target and Pathway
Target(s) Metabotropic glutamate receptor 5 Target Info Inhibitor [530843]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Long-term potentiation
Retrograde endocannabinoid signaling
Glutamatergic synapse
Huntington's disease
PANTHER Pathway Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway
Metabotropic glutamate receptor group III pathway
Metabotropic glutamate receptor group I pathway
Endogenous cannabinoid signaling
Reactome G alpha (q) signalling events
Class C/3 (Metabotropic glutamate/pheromone receptors)
WikiPathways Hypothetical Network for Drug Addiction
GPCRs, Class C Metabotropic glutamate, pheromone
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
References
Ref 530843Bioorg Med Chem. 2010 May 1;18(9):3026-35. Epub 2010 Mar 27.Structure-activity relationships in a novel series of 7-substituted-aryl quinolines and 5-substituted-aryl benzothiazoles at the metabotropic glutamate receptor subtype 5.
Ref 530843Bioorg Med Chem. 2010 May 1;18(9):3026-35. Epub 2010 Mar 27.Structure-activity relationships in a novel series of 7-substituted-aryl quinolines and 5-substituted-aryl benzothiazoles at the metabotropic glutamate receptor subtype 5.